Pediatric Oncology Experimental Therapeutics Investigation Consortium   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: CO United States (2003)

Organization Overview

First Clinical Trial
2009
NCT00782626
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Pediatric Oncology Experimental Therapeutics Investigators' Consortium